Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer. [electronic resource]
Producer: 20180227Description: 48 p. digitalISSN:- 1471-2407
- Aged
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Biomarkers, Tumor
- Camptothecin -- analogs & derivatives
- Colorectal Neoplasms -- drug therapy
- DNA Topoisomerases, Type I -- genetics
- Disease-Free Survival
- Female
- Gene Dosage
- Humans
- Irinotecan
- Liver Neoplasms -- secondary
- Lung Neoplasms -- secondary
- Male
- Middle Aged
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.